Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6977)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2013 (publication date) through May 14, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Al Dhibi HA, Arevalo JF. Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes 2013; 4(6): 295-302 [PMID: 24379920 DOI: 10.4239/wjd.v4.i6.295] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v4/i6/295.htm |
| Number | Citing Articles |
| 1 |
Mücella Arıkan Yorgun, Yasin Toklu, Melek Mutlu, Betül Seher Uysal, Hasan Basri Çakmak. Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema. International Ophthalmology 2016; 36(4): 531 doi: 10.1007/s10792-015-0155-6
|
| 2 |
Yanan Zhu, Chaohui Sun, Xin Zhang, Xingchao Shentu. Ptosis induced by topical steroid eye drops. Medicine 2017; 96(51): e9288 doi: 10.1097/MD.0000000000009288
|
| 3 |
Mohammad Ali Sadiq, Aniruddha Agarwal, Mohamed K Soliman, Mostafa Hanout, Salman Sarwar, Diana V Do, Quan Dong Nguyen. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation. Expert Opinion on Drug Safety 2015; 14(7): 1147 doi: 10.1517/14740338.2015.1041916
|
| 4 |
Elizabeth A. Atchison, Sophie J. Bakri. Intraocular Pressure after Intravitreal Triesence Injection. Seminars in Ophthalmology 2018; 33(3): 308 doi: 10.1080/08820538.2016.1229341
|
| 5 |
Stefano Fogli, Selene Mogavero, Colin Gerard Egan, Marzia Del Re, Romano Danesi. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema. Pharmacological Research 2016; 103: 149 doi: 10.1016/j.phrs.2015.11.003
|
| 6 |
José Juan Escobar-Barranco, Begoña Pina-Marín, Manel Fernández-Bonet. Dexamethasone Implants in Patients with Naïve or Refractory Diffuse Diabetic Macular Edema. Ophthalmologica 2015; 233(3-4): 176 doi: 10.1159/000371770
|
| 7 |
Enzhong Jin, Ling Luo, Yujing Bai, Mingwei Zhao. Comparative Effectiveness of Intravitreal Bevacizumab With or Without Triamcinolone Acetonide for Treatment of Diabetic Macular Edema. Annals of Pharmacotherapy 2015; 49(4): 387 doi: 10.1177/1060028014568006
|
| 8 |
Giuseppe Lo Giudice, Antonio Avarello, Gianluca Campana, Alessandro Galan. Rapid response to dexamethasone intravitreal implant in diabetic macular edema. European Journal of Ophthalmology 2018; 28(1): 74 doi: 10.5301/ejo.5000989
|
| 9 |
Vanessa Andrés-Guerrero, Irene Bravo-Osuna, Pilar Pastoriza, Irene T. Molina-Martinez, Rocío Herrero-Vanrell. Novel technologies for the delivery of ocular therapeutics in glaucoma. Journal of Drug Delivery Science and Technology 2017; 42: 181 doi: 10.1016/j.jddst.2017.07.001
|
| 10 |
Mihir Shah, Sara Cabrera-Ghayouri, Lori-Ann Christie, Katherine S. Held, Veena Viswanath. Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development. Pharmaceutical Research 2019; 36(4) doi: 10.1007/s11095-019-2588-5
|
| 11 |
Mari Pesonen, Eila Kankaanpää, Pasi Vottonen. Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model. Acta Ophthalmologica 2021; 99(7) doi: 10.1111/aos.14745
|
| 12 |
Amin Hatamnejad, Samantha Orr, Rohan Dadak, Arshad Khanani, Rishi Singh, Netan Choudhry. Anti‐VEGF and steroid combination therapy relative to anti‐VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta‐analysis of safety. Acta Ophthalmologica 2024; 102(3) doi: 10.1111/aos.15724
|
| 13 |
Angelo Maria Minnella, Martina Maceroni, Stefano Maria Picardi, Giorgio Placidi, Elisa De Siena, Stanislao Rizzo, Benedetto Falsini. Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function. Advances in Therapy 2020; 37(11): 4675 doi: 10.1007/s12325-020-01506-8
|
| 14 |
Bozho Todorich, Tamer H. Mahmoud. Vitrectomy for Diabetic Macular Edema. Current Ophthalmology Reports 2014; 2(4): 167 doi: 10.1007/s40135-014-0052-6
|
| 15 |
Focke Ziemssen, Hansjürgen T. Agostini. Anti-Angiogenic Therapy in Ophthalmology. Essentials in Ophthalmology 2016; : 89 doi: 10.1007/978-3-319-24097-8_6
|
| 16 |
Patricia Udaondo, Ana Hervas-Ontiveros, Amir Rosemblatt, Salvador Garcia-Delpech. Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes. Clinical Ophthalmology 2021; : 4153 doi: 10.2147/OPTH.S336865
|
| 17 |
Claudio Bucolo, Giuseppe Grosso, Valentina Drago, Caterina Gagliano. Intravitreal Triamcinolone Acetonide in the Treatment of Ophthalmic Inflammatory Diseases with Macular Edema: A Meta-Analysis Study. Journal of Ocular Pharmacology and Therapeutics 2015; 31(4): 228 doi: 10.1089/jop.2014.0094
|
| 18 |
Sadık Görkem Çevik, Sami Yılmaz, Mediha Tok Çevik, Fatma Düriye Akalp, Remzi Avcı. Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema. Journal of Ophthalmology 2018; 2018: 1 doi: 10.1155/2018/1757494
|
| 19 |
Francesco Boscia, Daniele Veritti, Cristiana Iaculli, Rosangela Lattanzio, Simona Freda, Benedetta Piergentili, Monica Varano. Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data. European Journal of Ophthalmology 2024; doi: 10.1177/11206721241237069
|